Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis
Public ClinicalTrials.gov record NCT00645073. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IV Comparative Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis
Study identification
- NCT ID
- NCT00645073
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Abbott
- Industry
- Enrollment
- 271 participants
Conditions and interventions
Conditions
Interventions
- cefdinir (Omnicef) Drug
- levofloxacin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2003
- Primary completion
- Feb 29, 2004
- Completion
- Not listed
- Last update posted
- Mar 26, 2008
Started 2003
United States locations
- U.S. sites
- 23
- U.S. states
- 12
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35211 | — |
| Not listed | Birmingham | Alabama | 35215 | — |
| Not listed | Columbiana | Alabama | 35051 | — |
| Not listed | Eclectic | Alabama | 36024 | — |
| Not listed | Tuscaloosa | Alabama | 35406 | — |
| Not listed | Mesa | Arizona | 85201 | — |
| Not listed | Fresno | California | 93703 | — |
| Not listed | Fresno | California | 93710 | — |
| Not listed | Murray | Kentucky | 42071 | — |
| Not listed | Portage | Michigan | 49024 | — |
| Not listed | Eugene | Oregon | 97404 | — |
| Not listed | Lake Oswego | Oregon | 97035 | — |
| Not listed | Orangeburg | South Carolina | 29118 | — |
| Not listed | Kingsport | Tennessee | 37660 | — |
| Not listed | Milan | Tennessee | 38358 | — |
| Not listed | Corsicana | Texas | 75110 | — |
| Not listed | San Antonio | Texas | 78205 | — |
| Not listed | Salt Lake City | Utah | 84109 | — |
| Not listed | Salt Lake City | Utah | 84121 | — |
| Not listed | West Jordan | Utah | 84084 | — |
| Not listed | West Jordan | Utah | 84088 | — |
| Not listed | Winchester | Virginia | 22601 | — |
| Not listed | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00645073, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 26, 2008 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00645073 live on ClinicalTrials.gov.